Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
1.82
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-0.86 Insider Own27.55% Shs Outstand32.17M Perf Week-3.70%
Market Cap70.98M Forward P/E- EPS next Y-1.28 Insider Trans0.06% Shs Float28.25M Perf Month-10.78%
Income-25.79M PEG- EPS next Q-0.24 Inst Own17.06% Short Float0.81% Perf Quarter-3.70%
Sales0.00M P/S- EPS this Y-17.83% Inst Trans-0.79% Short Ratio1.08 Perf Half Y35.82%
Book/sh0.76 P/B2.39 EPS next Y-26.64% ROA-60.26% Short Interest0.23M Perf Year-10.78%
Cash/sh0.77 P/C2.37 EPS next 5Y- ROE-79.69% 52W Range0.90 - 3.49 Perf YTD-1.62%
Dividend Est.- P/FCF- EPS past 5Y-21.09% ROI-105.37% 52W High-47.85% Beta1.62
Dividend TTM- Quick Ratio3.37 Sales past 5Y0.00% Gross Margin- 52W Low102.20% ATR (14)0.14
Dividend Ex-Date- Current Ratio3.37 EPS Y/Y TTM3.78% Oper. Margin0.00% RSI (14)42.00 Volatility5.61% 7.12%
Employees28 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price7.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-48.01% Payout- Rel Volume0.90 Prev Close1.82
Sales Surprise- EPS Surprise15.62% Sales Q/Q- EarningsMar 26 BMO Avg Volume210.69K Price1.82
SMA20-4.54% SMA50-12.73% SMA2005.86% Trades Volume189,557 Change0.00%
Date Action Analyst Rating Change Price Target Change
Nov-03-21Initiated Oppenheimer Outperform $22
Nov-03-21Initiated B. Riley Securities Buy $27
Mar-27-24 09:31AM
01:13AM
Mar-26-24 11:53AM
07:00AM
Mar-15-24 07:30AM
04:05PM Loading…
Mar-14-24 04:05PM
Mar-11-24 08:16PM
04:05PM
Mar-06-24 07:30AM
Feb-26-24 07:30AM
Feb-06-24 08:47AM
Jan-04-24 07:30AM
Nov-16-23 07:30AM
Nov-15-23 07:30AM
Nov-07-23 07:30AM
06:00AM Loading…
Nov-03-23 06:00AM
Nov-02-23 07:30AM
Oct-27-23 07:30AM
Oct-24-23 04:30PM
Oct-16-23 07:30AM
Sep-07-23 07:45AM
Aug-30-23 08:00AM
Aug-09-23 09:09AM
Aug-08-23 09:52PM
07:00AM
Aug-02-23 07:30AM
Jul-11-23 07:30AM
Jul-05-23 07:30AM
Jun-28-23 07:00AM
Jun-27-23 07:17PM
07:30AM Loading…
Jun-20-23 07:30AM
Jun-02-23 07:30AM
May-23-23 09:40AM
07:30AM
May-18-23 03:53PM
07:30AM
May-04-23 04:05PM
May-01-23 07:30AM
Apr-19-23 07:30AM
Apr-12-23 07:30AM
Mar-28-23 07:30AM
Mar-27-23 08:00AM
07:12AM
Mar-23-23 11:03PM
07:30AM
Mar-21-23 08:00AM
Mar-16-23 12:18PM
07:30AM
Mar-15-23 07:30AM
Mar-07-23 08:00AM
Feb-22-23 08:00AM
Feb-21-23 07:30AM
Feb-20-23 08:50AM
Feb-09-23 08:00AM
Dec-22-22 08:00AM
Dec-21-22 04:05PM
Dec-15-22 08:00AM
Dec-01-22 08:38AM
07:30AM
Nov-28-22 08:00AM
Nov-21-22 08:00AM
Nov-15-22 12:55PM
Nov-14-22 08:00AM
Nov-10-22 08:00AM
Oct-12-22 08:00AM
Oct-11-22 08:00AM
Sep-29-22 07:30AM
Sep-27-22 07:32AM
Sep-06-22 07:32AM
Aug-11-22 06:56AM
Aug-09-22 07:00AM
Aug-04-22 04:02PM
02:30PM
Aug-03-22 04:05PM
Jul-19-22 08:00AM
Jun-23-22 07:30AM
Jun-08-22 07:30AM
Jun-02-22 04:01PM
May-13-22 07:30AM
May-11-22 07:00AM
May-04-22 05:54PM
04:01PM
May-03-22 08:00AM
May-02-22 11:18AM
Apr-25-22 04:01PM
08:00AM
Apr-06-22 07:30AM
Mar-30-22 07:00AM
Mar-22-22 08:00AM
Mar-10-22 07:30AM
Mar-08-22 08:00AM
Feb-08-22 07:30AM
Jan-10-22 07:30AM
Jan-08-22 07:01AM
Jan-04-22 07:30AM
Dec-21-21 07:30AM
Nov-30-21 07:30AM
Nov-18-21 08:00AM
Nov-15-21 07:30AM
Nov-03-21 08:00AM
Cognition Therapeutics, Inc. is a clinical stage neuroscience company, which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer's disease, dry age-related macular degeneration, geographic atrophy, and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ricciardi LisaCEO & PresidentMar 14 '24Buy1.755,7009,975291,345Mar 14 04:34 PM